Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial
K Dickstein, J Kjekshus - The Lancet, 2002 - thelancet.com
Background ACE inhibitors attenuate the detrimental effects of angiotensin II, and improve
survival and reduce morbidity in patients with acute myocardial infarction and evidence of …
survival and reduce morbidity in patients with acute myocardial infarction and evidence of …
Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: evidence from clinical trials
GV Moukarbel, SD Solomon - Current heart failure reports, 2008 - Springer
Following acute myocardial infarction, patients are at increased risk of developing heart
failure, which is more prevalent in those with reduced ventricular systolic function. Activation …
failure, which is more prevalent in those with reduced ventricular systolic function. Activation …
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
N Bissessor, H White - Vascular health and risk management, 2007 - Taylor & Francis
The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
Valsartan, Captopril, or Both in Myocardial Infarction [2](multiple letters)
JH McAnulty, R Moshenyat, Y Kupfer… - … England Journal of …, 2004 - einstein.elsevierpure.com
Results:-AdverseEffects: An unspecified number of patients had hypotension, renal
dysfunction, hyperkalemia, and cough. FreeText: Comments on Diovan and reply. The study …
dysfunction, hyperkalemia, and cough. FreeText: Comments on Diovan and reply. The study …
[PDF][PDF] ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure
JA Gold, PS Rahko - WMJ-MADISON-, 2004 - researchgate.net
The differences in outcome using losartan, as compared to the new trials with valsartan and
candesartan, also raise the question of whether the results achieved by valsartan and …
candesartan, also raise the question of whether the results achieved by valsartan and …
Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing
SG Ball, AS Hall, GD Murray - Journal of the American College of …, 1995 - Elsevier
A number of major studies have examined the impact of angiotensin-converting enzyme
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …
[HTML][HTML] Angiotensin receptor–neprilysin inhibition in acute myocardial infarction
Background In patients with symptomatic heart failure, sacubitril–valsartan has been found
to reduce the risk of hospitalization and death from cardiovascular causes more effectively …
to reduce the risk of hospitalization and death from cardiovascular causes more effectively …
Angiotensin Receptor-Neprilysin Inhibitor in Acute Myocardial Infarction.
P Pathak - The Journal of the Association of Physicians of India, 2022 - europepmc.org
Angiotensin Receptor-Neprilysin Inhibitor in Acute Myocardial Infarction. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
[PDF][PDF] Angiotensin-receptor blockade in acute myocardial infarction-a matter of dose
DL Mann, A Deswal - New England Journal of Medicine, 2003 - researchgate.net
Beta-blockers, angiotensin-converting–enzyme (ACE) inhibitors, and aldosterone
antagonists have been shown to reduce the overall risk of death as well as the risk of major …
antagonists have been shown to reduce the overall risk of death as well as the risk of major …